|
2-丙基-4-五烯酸
|
P695457-50mg
|
analytical standard, ≥97.0%(GC) |
1575-72-0 |
50mg
|
¥ 2299.9
|
现货 |
|
0 |
阿拉丁 |
|
2-丙基-4-五烯酸
|
P695457-10mg
|
analytical standard, ≥97.0%(GC) |
1575-72-0 |
10mg
|
¥ 699.9
|
现货 |
|
0 |
阿拉丁 |
|
2-丙基-4-五烯酸
|
P695457-100mg
|
analytical standard, ≥97.0%(GC) |
1575-72-0 |
100mg
|
¥ 3699.9
|
现货 |
|
0 |
阿拉丁 |
|
草酸标准溶液
|
O742393-500ml
|
c(1/2H2C2O4)=0.1000mol/L |
144-62-7 |
500ml
|
¥ 193.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
6-羟基-4-(三氟甲基)烟酸
|
O634663-100mg
|
≥97% |
849020-87-7 |
100mg
|
¥ 179.9
|
现货 |
|
0 |
阿拉丁 |
|
硝酸盐标准溶液
|
N742339-500ml
|
100μg/mL(as Nitrate) |
7757-79-1 |
500ml
|
¥ 500.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
总氮标准溶液
|
N742313-500ml
|
100μg/ml in water |
N/A |
500ml
|
¥ 700.9
|
现货 |
|
0 |
阿拉丁 |
|
镁标准溶液
|
M742309-500ml
|
100μg/mL |
7439-95-4 |
500ml
|
¥ 759.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
锰标准溶液
|
M742278-500ml
|
100μg/mL |
7439-96-5 |
500ml
|
¥ 1949.9
|
现货 |
|
0 |
阿拉丁 |
|
钼标准溶液
|
M742255-500ml
|
100μg/mL |
7439-98-7 |
500ml
|
¥ 1919.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
CD64 Mouse mAb (FITC)
|
Ab185384-10T
|
ExactAb™, 已验证, Ex:498nm, Em:517nm, 5 μL/test |
N/A |
10T
|
¥ 239.92
|
现货 |
|
0 |
阿拉丁 |
|
CD45RO Mouse mAb (FITC)
|
Ab178870-10T
|
ExactAb™, 已验证, Ex:498nm, Em:517nm, 5 μL/test |
N/A |
10T
|
¥ 87.92
|
现货 |
|
0 |
阿拉丁 |
|
FoxP3 Mouse mAb
|
Ab156559-10μl
|
ExactAb™, Validated, Carrier Free, Azide Free, High performance, ≥95%(SDS-PAGE), 1.0 mg/mL |
N/A |
10μl
|
¥ 399.92
|
现货 |
|
0 |
阿拉丁 |
|
CD34 Mouse mAb
|
Ab156191-10μg
|
Carrier Free, ExactAb™, Validated, Azide Free, High performance, ≥95%(SDS-PAGE), 1.0 mg/mL |
N/A |
10μg
|
¥ 215.92
|
现货 |
|
0 |
阿拉丁 |
|
铝标准溶液
|
A105851-100ml
|
分析标准品, 1000ug/ml in 1.0 mol/L HNO3 |
7429-90-5 |
100ml
|
¥ 359.9
|
现货 |
|
0 |
阿拉丁 |
|
Erlizumab (anti-CD18)
|
Ab183450-100μg
|
无载体, 重组, ExactAb™, 低内毒素, 无叠氮钠, 已验证, 无动物源, ≥95%(SDS-PAGE&SEC-HPLC), 见COA |
211323-03-4 |
100μg
|
¥ 535.92
|
现货 |
|
0 |
阿拉丁 |
|
Visugromab (anti-GDF15)
|
Ab182987-100μg
|
无载体, 重组, ExactAb™, 低内毒素, 无叠氮钠, 已验证, 无动物源, ≥95%(SDS-PAGE&SEC-HPLC), 见COA |
2556646-63-8 |
100μg
|
¥ 579.9
|
现货 |
|
0 |
阿拉丁 |
|
Uliledlimab (anti-CD73)
|
Ab182937-100μg
|
无载体, 重组, ExactAb™, 低内毒素, 无叠氮钠, 已验证, 无动物源, ≥95%(SDS-PAGE&SEC-HPLC), 见COA |
2378407-27-1 |
100μg
|
¥ 579.9
|
现货 |
|
0 |
阿拉丁 |
|
Levilimab (anti-IL-6Ra)
|
Ab182913-100μg
|
无载体, 重组, ExactAb™, 低内毒素, 无叠氮钠, 已验证, 无动物源, ≥95%(SDS-PAGE&SEC-HPLC), 见COA |
2035008-70-7 |
100μg
|
¥ 535.92
|
现货 |
|
0 |
阿拉丁 |
|
Ravagalimab (anti-CD40)
|
Ab182860-100μg
|
无载体, 重组, ExactAb™, 低内毒素, 无叠氮钠, 已验证, 无动物源, ≥95%(SDS-PAGE&SEC-HPLC), 见COA |
2050816-56-1 |
100μg
|
¥ 669.9
|
现货 |
|
0 |
阿拉丁 |
|
Gatipotuzumab (anti-MUC1)
|
Ab182788-100μg
|
无载体, 重组, ExactAb™, 低内毒素, 无叠氮钠, 已验证, 无动物源, ≥95%(SDS-PAGE&SEC-HPLC), 见COA |
1264737-26-9 |
100μg
|
¥ 749.9
|
现货 |
|
0 |
阿拉丁 |
|
Marstacimab (anti-TFPI)
|
Ab182783-100μg
|
无载体, 重组, ExactAb™, 低内毒素, 无叠氮钠, 已验证, 无动物源, ≥95%(SDS-PAGE&SEC-HPLC), 见COA |
1985638-39-8 |
100μg
|
¥ 669.9
|
现货 |
|
0 |
阿拉丁 |
|
Gancotamab (anti-HER2)
|
Ab182761-100μg
|
无载体, 重组, ExactAb™, 低内毒素, 无叠氮钠, 已验证, 无动物源, ≥95%(SDS-PAGE&SEC-HPLC), 见COA |
1509928-00-0 |
100μg
|
¥ 669.9
|
现货 |
|
0 |
阿拉丁 |
|
Vilobelimab (anti-Complement C5)
|
Ab182712-100μg
|
无载体, 重组, ExactAb™, 低内毒素, 无叠氮钠, 已验证, 无动物源, ≥95%(SDS-PAGE&SEC-HPLC), 见COA |
2250440-41-4 |
100μg
|
¥ 569.9
|
现货 |
|
0 |
阿拉丁 |